Skip to main content

Monte Rosa Therapeutics, Inc.

GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001826457

In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.

13F holders, Q4 2025

Institutional positions in Monte Rosa Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
161
+33 vs. Q3 2025
Shares held
64.5M
+4.44M (+7.4%) vs. Q3 2025
Total value
$1.01B
+$566.1M (+127.3%) vs. Q3 2025
New holders
49
54 more added
Sold out
16
39 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 161 institutions
Q1 2021: 0 institutionsQ2 2021: 48 institutionsQ3 2021: 56 institutionsQ4 2021: 53 institutionsQ1 2022: 52 institutionsQ2 2022: 57 institutionsQ3 2022: 70 institutionsQ4 2022: 66 institutionsQ1 2023: 69 institutionsQ2 2023: 68 institutionsQ3 2023: 71 institutionsQ4 2023: 71 institutionsQ1 2024: 68 institutionsQ2 2024: 75 institutionsQ3 2024: 81 institutionsQ4 2024: 105 institutionsQ1 2025: 106 institutionsQ2 2025: 116 institutionsQ3 2025: 129 institutionsQ4 2025: 161 institutionsQ1 2026: 191 institutionsQ2 2026: 192 institutions
Value heldQ4 2025: $1.01B
Q1 2021: $0Q2 2021: $705.1MQ3 2021: $759.4MQ4 2021: $742.0MQ1 2022: $559.9MQ2 2022: $375.0MQ3 2022: $328.8MQ4 2022: $313.8MQ1 2023: $309.8MQ2 2023: $272.3MQ3 2023: $201.4MQ4 2023: $226.6MQ1 2024: $281.3MQ2 2024: $171.7MQ3 2024: $263.7MQ4 2024: $423.3MQ1 2025: $276.2MQ2 2025: $280.6MQ3 2025: $444.9MQ4 2025: $1.01BQ1 2026: $1.43BQ2 2026: $2.24B
Institutions holding GLUE and their total value by quarter
QuarterHoldersValue
Q2 2026192$2.24B
Q1 2026191$1.43B
Q4 2025161$1.01B
Q3 2025129$444.9M
Q2 2025116$280.6M
Q1 2025106$276.2M
Q4 2024105$423.3M
Q3 202481$263.7M
Q2 202475$171.7M
Q1 202468$281.3M
Q4 202371$226.6M
Q3 202371$201.4M
Q2 202368$272.3M
Q1 202369$309.8M
Q4 202266$313.8M
Q3 202270$328.8M
Q2 202257$375.0M
Q1 202252$559.9M
Q4 202153$742.0M
Q3 202156$759.4M
Q2 202148$705.1M
Q1 20210$0

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Monte Rosa Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding GLUE in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Rhumbline Advisers61,859$969.9K0.00%−2,087−3.3%Reduced
Diadema Partners LP62,281$976.6K0.58%+62,281New
Advisory Research Inc63,220$991.3K0.12%+63,220New
Alliancebernstein L.P.63,480$995.4K0.00%00.0%Unchanged
Rafferty Asset Management, LLC67,438$1.06M0.00%+67,438New
Rangeley Capital, LLC67,500$1.06M0.91%−45,500−40.3%Reduced
Canada Pension Plan Investment Board68,100$1.07M0.00%+68,100New
EAM Investors, LLC70,037$1.10M0.12%+70,037New
Franklin Resources Inc85,231$1.34M0.00%+41,811+96.3%Added
D. E. Shaw & Co., Inc.85,488$1.34M0.00%+35,275+70.3%Added
Casdin Capital, LLC86,014$1.35M0.08%00.0%Unchanged
Ieq Capital, LLC89,268$1.40M0.00%+30,202+51.1%Added
Campbell & CO Investment Adviser LLC90,752$1.42M0.07%+39,619+77.5%Added
Millennium Management LLC103,972$1.63M0.00%−340,967−76.6%Reduced
Ameriprise Financial Inc122,164$1.92M0.00%+122,164New
UBS Group AG123,000$1.93M0.00%+50,905+70.6%Added
Barclays PLC135,984$2.13M0.00%+63,029+86.4%Added
Manufacturers Life Insurance Company, The134,674$2.15M0.00%+16,291+13.8%Added
Jane Street Group, LLC137,049$2.15M0.00%−170,000−55.4%Reduced
Atom Investors LP137,261$2.15M0.17%+137,261New
Wellington Management Group LLP148,057$2.32M0.00%−10,467−6.6%Reduced
Trexquant Investment LP149,712$2.35M0.02%+149,712New
Bank of New York Mellon Corp173,304$2.72M0.00%−13,494−7.2%Reduced
Nomura Asset Management International Inc.200,000$3.14M0.00%+200,000New
TD Asset Management Inc213,464$3.35M0.00%+41,386+24.1%Added
ADAR1 Capital Management, LLC215,752$3.38M0.25%00.0%Unchanged
Bank of America Corp223,571$3.51M0.00%−46,072−17.1%Reduced
Acadian Asset Management LLC247,855$3.88M0.01%+44,305+21.8%Added
Empowered Funds, LLC278,077$4.36M0.07%+190,627+218.0%Added
Nextech Invest, Ltd.279,237$4.38M0.42%+279,237New
Nuveen, LLC285,859$4.48M0.00%+182,891+177.6%Added
Goldman Sachs Group Inc295,878$4.64M0.00%+194,734+192.5%Added
Arrowstreet Capital, Limited Partnership307,651$4.82M0.00%+307,651New
Invesco Ltd.362,213$5.68M0.00%+264,315+270.0%Added
Marshall Wace, LLP398,890$6.25M0.01%−503,944−55.8%Reduced
Charles Schwab Investment Management Inc448,714$7.04M0.00%+65,446+17.1%Added
Bridgeway Capital Management, LLC523,377$8.21M0.17%+164,527+45.8%Added
Dimensional Fund Advisors LP568,367$8.91M0.00%−63,815−10.1%Reduced
Northern Trust Corp697,034$10.9M0.00%−43,650−5.9%Reduced
Parkwood LLC708,000$11.1M0.94%00.0%Unchanged
Alphabet Inc.744,948$11.7M0.45%−719,067−49.1%Reduced
Vestal Point Capital, LP775,000$12.2M0.45%−25,000−3.1%Reduced
AQR Capital Management LLC785,057$12.3M0.01%+67,795+9.5%Added
Morgan Stanley805,530$12.6M0.00%+160,334+24.9%Added
Braidwell LP948,316$14.9M0.48%+948,316New
Silverarc Capital Management, LLC1,029,066$16.1M2.33%+334,124+48.1%Added
MPM Oncology Impact Management LP1,173,376$18.4M2.11%+1,173,376New
Geode Capital Management, LLC1,204,844$18.9M0.00%+53,278+4.6%Added
FMR LLC1,300,096$20.4M0.00%−1,512,155−53.8%Reduced
American Century Companies Inc1,329,619$20.8M0.01%+736,225+124.1%Added
Aisling Capital Management LP1,472,331$23.1M4.82%00.0%Unchanged
State Street Corp2,107,480$33.0M0.00%+1,260,707+148.9%Added
Vanguard Group Inc3,246,500$50.9M0.00%+257,547+8.6%Added
Suvretta Capital Management, LLC3,360,000$52.7M1.31%00.0%Unchanged
BVF Inc3,835,886$60.1M2.02%−1,824,246−32.2%Reduced
BlackRock, Inc.4,181,161$65.6M0.00%+366,028+9.6%Added
Baker Bros. Advisors LP4,345,736$68.1M0.40%−570,359−11.6%Reduced
Versant Venture Management, LLC4,382,687$68.7M45.49%−1,270,235−22.5%Reduced
TCG Crossover Management, LLC4,622,151$72.5M2.40%+4,622,151New
Price T Rowe Associates Inc5,118,904$80.3M0.01%+481,844+10.4%Added
NEA Management Company, LLC7,692,298$120.6M6.15%00.0%Unchanged
Balyasny Asset Management LLC0$00.00%−408,540−100.0%Sold out
Renaissance Technologies LLC0$00.00%−395,733−100.0%Sold out
Macquarie Group Ltd0$00.00%−200,000−100.0%Sold out
JBF Capital, Inc.0$00.00%−148,566−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−147,726−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−90,419−100.0%Sold out
Mackenzie Financial Corp0$00.00%−77,635−100.0%Sold out
Omers Administration Corp0$00.00%−28,300−100.0%Sold out
Bailard, Inc.0$00.00%−22,500−100.0%Sold out
Scientech Research LLC0$00.00%−16,254−100.0%Sold out
Prudential Financial Inc0$00.00%−12,054−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−11,100−100.0%Sold out
Royce & Associates LP0$00.00%−11,024−100.0%Sold out
Engineers Gate Manager LP0$00.00%−10,871−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−10,202−100.0%Sold out
Summit Wealth Group LLC0$00.00%−2,002−100.0%Sold out
Point72 Europe (London) LLP––––Not filed